Highbridge Capital Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-35,478
| Closed | -$149K | – | 1349 |
|
|
2017
Q1 | $149K | Buy |
+35,478
| New | +$149K | ﹤0.01% | 1013 |
|
|
2016
Q4 | – | Sell |
-154,916
| Closed | -$1.26M | – | 1431 |
|
|
2016
Q3 | $1.26M | Buy |
154,916
+126,044
| +437% | +$1.02M | 0.02% | 461 |
|
|
2016
Q2 | $225K | Buy |
+28,872
| New | +$225K | ﹤0.01% | 902 |
|
|
2015
Q3 | – | Sell |
-291,981
| Closed | -$2.59M | – | 1222 |
|
|
2015
Q2 | $2.59M | Buy |
291,981
+31,504
| +12% | +$279K | 0.03% | 369 |
|
|
2015
Q1 | $2.57M | Buy |
+260,477
| New | +$2.57M | 0.04% | 370 |
|
|
2014
Q4 | – | Sell |
-51,453
| Closed | -$513K | – | 1108 |
|
|
2014
Q3 | $513K | Sell |
51,453
-37,218
| -42% | -$371K | 0.01% | 630 |
|
|
2014
Q2 | $671K | Buy |
88,671
+39,806
| +81% | +$301K | 0.01% | 481 |
|
|
2014
Q1 | $161K | Buy |
+48,865
| New | +$161K | ﹤0.01% | 656 |
|
|
2013
Q4 | – | Sell |
-50,743
| Closed | -$153K | – | 1052 |
|
|
2013
Q3 | $153K | Buy |
+50,743
| New | +$153K | ﹤0.01% | 852 |
|